BCPC — Balchem Income Statement
0.000.00%
- $4.79bn
- $4.92bn
- $953.68m
- 96
- 29
- 57
- 65
Annual income statement for Balchem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
| 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 704 | 799 | 942 | 922 | 954 | 
| Cost of Revenue | |||||
| Gross Profit | 224 | 243 | 280 | 302 | 336 | 
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 592 | 672 | 797 | 763 | 771 | 
| Operating Profit | 111 | 128 | 145 | 159 | 183 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 106 | 125 | 134 | 137 | 166 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | 84.6 | 96.1 | 105 | 109 | 128 | 
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 84.6 | 96.1 | 105 | 109 | 128 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 84.6 | 96.1 | 105 | 109 | 128 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.68 | 2.97 | 3.32 | 3.29 | 3.95 | 
| Dividends per Share |